Goldman Sachs
AGN

Goldman Sachs’s Allergan plc AGN Stock Holding History

Goldman Sachs’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-50,300
Closed -$9.62M – 5708
2019
Q4 		$9.62M Buy
50,300
+12,000
+31% +$2.16M ﹤0.01% 2457
2019
Q3 		$6.45M Sell
38,300
-170,200
-82% -$27.7M ﹤0.01% 2668
2019
Q2 		$34.9M Buy
208,500
+125,700
+152% +$17.4M 0.01% 1412
2019
Q1 		$12.1M Buy
82,800
+43,900
+113% +$6.36M ﹤0.01% 2269
2018
Q4 		$5.2M Buy
38,900
+19,200
+97% +$3.15M ﹤0.01% 2844
2018
Q3 		$3.75M Buy
19,700
+6,900
+54% +$1.27M ﹤0.01% 3191
2018
Q2 		$2.13M Sell
12,800
-25,700
-67% -$4.13M ﹤0.01% 3589
2018
Q1 		$6.48M Sell
38,500
-98,200
-72% -$16.5M ﹤0.01% 2700
2017
Q4 		$22.4M Sell
136,700
-71,700
-34% -$12.9M 0.01% 1854
2017
Q3 		$42.7M Sell
208,400
-291,900
-58% -$67.9M 0.01% 1405
2017
Q2 		$122M Buy
500,300
+89,400
+22% +$21M 0.03% 651
2017
Q1 		$98.2M Sell
410,900
-166,300
-29% -$38.7M 0.03% 763
2016
Q4 		$121M Sell
577,200
-160,600
-22% -$33.3M 0.03% 653
2016
Q3 		$170M Sell
737,800
-420,000
-36% -$103M 0.05% 423
2016
Q2 		$268M Buy
1,157,800
+70,900
+7% +$16.3M 0.09% 226
2016
Q1 		$291M Sell
1,086,900
-145,368
-12% -$41.6M 0.1% 211
2015
Q4 		$385M Buy
1,232,268
+612,101
+99% +$182M 0.12% 159
2015
Q3 		$169M Buy
620,167
+393,900
+174% +$121M 0.06% 372
2015
Q2 		$68.7M Sell
226,267
-944,504
-81% -$282M 0.02% 890
2015
Q1 		$348M Sell
1,170,771
-330,154
-22% -$94.1M 0.11% 184
2014
Q4 		$386M Buy
1,500,925
+346,456
+30% +$86.6M 0.12% 157
2014
Q3 		$279M Buy
1,154,469
+558,541
+94% +$125M 0.09% 231
2014
Q2 		$133M Sell
595,928
-105,052
-15% -$21.8M 0.04% 531
2014
Q1 		$144M Buy
700,980
+531,656
+314% +$105M 0.05% 448
2013
Q4 		$28.4M Buy
169,324
+19,524
+13% +$3.05M 0.01% 1479
2013
Q3 		$21.6M Buy
149,800
+46,800
+45% +$6.23M 0.01% 1568
2013
Q2 		$13M Buy
+103,000
New +$11.7M 0.01% 1865

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Goldman Sachs's AGN Position: Q2 2020 in Review

Goldman Sachs sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 7,490,686 shares — an estimated $1.33B sold.

Goldman Sachs first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $1.45B in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Goldman Sachs reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Goldman Sachs sold 7,490,686 Allergan plc shares in Q2 2020, an estimated $1.33B.
  • Goldman Sachs first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • Goldman Sachs's Allergan plc position peaked at $1.45B in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Goldman Sachs's 13F filing for Q2 2020, filed 12 Aug 2020.